| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental cyclophosphamide poisoning |
Causative agent |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Intentional cyclophosphamide poisoning |
Causative agent |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| förgiftning orsakad av cyklofosfamid, med oklar avsikt |
Causative agent |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide adverse reaction |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Allergy to cyclophosphamide (finding) |
Causative agent |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide overdose |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Accidental cyclophosphamide overdose |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Intentional cyclophosphamide overdose |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| överdos av cyklofosfamid, med oklar avsikt |
Causative agent |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 50 mg oral tablet |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 200 milligram/injektionsflaska, pulver till injektionsvätska |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid 20 mg/ml, infusionsvätska, lösning, flaska 200 ml |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid 20 mg/ml, infusionsvätska, lösning, flaska 100 ml |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid 20 mg/ml, infusionsvätska, lösning, flaska 50 ml |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 100mg/vial injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 200mg/vial injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 500mg/vial injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 1g/vial injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 2g/vial injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 25 mg oral tablet |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid 100 mg/flaska, pulver till injektionsvätska |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid 1 000 mg/flaska, injektionsdos |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Product containing cyclophosphamide in oral dose form (medicinal product form) |
Has active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide-containing product in parenteral dose form |
Has active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by cyclophosphamide |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Product containing cyclophosphamide (medicinal product) |
Has active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 200mg/vial powder for injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 1g/vial powder for injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 500mg/vial powder for injection |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Accidental cyclophosphamide poisoning |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Intentional cyclophosphamide poisoning |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Allergy to cyclophosphamide (finding) |
Causative agent |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide therapy (procedure) |
Direct substance |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
2 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) |
Direct substance |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
8 |
| Cyclophosphamide monohydrate (substance) |
Is a |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 50 mg oral tablet |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 25 mg oral tablet |
Has active ingredient |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide monohydrate (substance) |
Is modification of (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
| Cyclophosphamide 25 mg oral tablet |
Has precise active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 50 mg oral tablet |
Has precise active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| cyklofosfamid (som cyklofosfamidmonohydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| cyklofosfamid (som cyklofosfamidmonohydrat) 200 milligram/injektionsflaska, pulver till injektionsvätska |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| cyklofosfamid (som cyklofosfamidmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Product containing only cyclophosphamide (medicinal product) |
Has active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide only product in oral dose form |
Has active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Product containing only cyclophosphamide in parenteral dose form (medicinal product form) |
Has active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy |
Direct substance |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
5 |
| Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 200 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 200 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 500 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 1 g powder for solution for injection vial |
Has precise active ingredient |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide 1 g powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
| Cyclophosphamide anhydrous (substance) |
Is modification of (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|